Results 131 to 140 of about 130,583 (297)

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN

open access: yesObesity, EarlyView.
ABSTRACT Objective SURMOUNT‐MAINTAIN aims to evaluate the efficacy and safety of reducing the tirzepatide dose and/or continuing the maximum tolerated dose (MTD) versus placebo in maintaining body weight (BW) reduction achieved with tirzepatide MTD. Methods This Phase 3b, multicenter, randomized, parallel‐arm, double‐blinded, placebo‐controlled, 52 ...
Deborah B. Horn   +9 more
wiley   +1 more source

TRANSCATHETER EMBOLIZATION OF RENAL CELL CARCINOMA

open access: bronze, 1975
Harvey M. Goldstein   +6 more
openalex   +1 more source

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The somatic activating variant in BRAF (p.V600E) was recently described as a novel cause of macrocystic head and neck lymphatic malformations in three individuals. Other recent studies profiling the genetic causes of more complex lymphatic anomalies identified this same pathogenic BRAF variant.
Michael D. Fox   +11 more
wiley   +1 more source

Embolized Disc from a Beall Mitral Valve Prosthesis [PDF]

open access: bronze, 1982
Chin C. Chen   +2 more
openalex   +1 more source

Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis

open access: yesPrenatal Diagnosis, EarlyView.
ABSTRACT Hereditary pyropoikilocytosis (HPP) is a severe hemolytic anemia caused by variants in SPTA1, SPTB, and EPB41. These weaken horizontal interactions in the erythrocyte cytoskeleton, causing membrane fragmentation and splenic sequestration. It will readily cause fetal anemia and often hydrops fetalis. Prenatal diagnosis requires first ruling out
Connor Hartzell   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy